Status:
COMPLETED
A Study to Gain Information How Well Dexpanthenol Dermal Spray Helps the Skin to Recover After a Peeling in the External Genital Area of Women
Lead Sponsor:
Bayer
Conditions:
Skin Recovery
Eligibility:
FEMALE
18-60 years
Phase:
PHASE4
Brief Summary
In this study, researchers want to learn more about the effect of dexpanthenol dermal spray on skin recovery after a dermatological procedure (peeling) in the intimate area of women. After the peelin...
Detailed Description
The primary objective is to evaluate the efficacy of the test product to aid skin recovery after peeling in the female intima and inguinal region. Secondary objectives comprise clinical efficacy with...
Eligibility Criteria
Inclusion
- Phototypes I and II according to the Fitzpatrick scale;
- Participants willing to have peeling in the genital area to improve the general appearance of the skin and bleaching of spots.
Exclusion
- Pathologies and/or skin injuries, such as psoriasis, sensitive skin, skin cancer, atopic dermatitis or other medical criteria to be considered at the time of evaluation
- Hyperpigmentation in the test area that interfere with the evaluation of possible reactions (vascular malformations, scars, increase of pilosity and large amount of nevi)
- Pathologies and/or active skin injuries (local and/or disseminated) in the evaluation area
Key Trial Info
Start Date :
February 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 13 2019
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT03853512
Start Date
February 12 2019
End Date
March 13 2019
Last Update
March 11 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medcin Instituto da Pele
São Paulo, Brazil, 06023-070